A-share subscription | Omicron (920080.BJ) opens subscription. The product can be used in the fields of electrical appliances, wind power and lithium battery new energy, etc.
On September 22, Ormeus Global (920080.BJ) initiated the subscription process.
On September 22nd, Aomeisen (920080.BJ) started its subscription, with an issue price of 8.25 yuan per share and a subscription ceiling of 950,000 shares, with a price-to-earnings ratio of 12.52 times. It belongs to the Beishang Exchange, and Cinda is its sponsor.
The prospectus disclosed that Aomeisen is a professional manufacturer of intelligent equipment, mainly engaged in the research, design, production, and sales of intelligent production equipment and production lines. The company's products can be widely used in the fields of electronics, environmental protection, wind power, lithium new energy, and other industries, and are key equipment to achieve production automation, intelligentization, and efficiency. The company has maintained long-term stable cooperation relationships with major domestic and foreign electrical appliance manufacturers such as Gree Electric Appliances, Inc. of Zhuhai, Midea Group Co., Ltd, Aux, Hisense Home Appliances Group, TCL Household Appliances, Sichuan Changhong Electric, Daikin Air Conditioning, Panasonic Electric, Johnson Controls, Telling, Carrier, Fujitsu General, Mitsubishi Heavy Industries Haier, etc.
During the reporting period, the main business income of Aomeisen includes the sales revenue of intelligent equipment for heat exchanger production, the sales revenue of intelligent equipment for pipeline processing, the sales revenue of other customized intelligent equipment, and the sales revenue of components and other products.
According to the data, heat exchangers are important components in air conditioning equipment, and the quality of heat exchangers directly affects important indicators such as the energy efficiency ratio and reliability of air conditioners. There are various types of heat exchangers used in air conditioning products, including fin tube heat exchangers, plate heat exchangers, microchannel heat exchangers, etc., with fin tube heat exchangers being the most commonly used type at present.
The main upgrade direction of air conditioning heat exchangers is to use thin-walled small-diameter copper tubes (usually with a diameter of 5mm or less) to replace the larger-diameter copper tubes in existing heat exchangers. Compared to larger-diameter heat exchangers, small-diameter heat exchangers have a higher surface area/volume ratio, a higher heat transfer coefficient, which is beneficial for improving the overall performance of the air conditioner, and significant cost reductions.
Aomeisen, as an intelligent equipment manufacturer in the upstream of the air conditioning industry, relies on its core technology to produce a non-shrinkage forced expansion machine that can form fin tube heat exchangers with a minimum diameter of 3.4mm. Taking 5mm copper tubes as an example, by using 5mm copper tubes instead of the original 9.52mm copper tubes, the heat transfer coefficient can increase by about 10%, the cost can be reduced by more than 50%, and the refrigerant charge can be reduced by about 75%.
In terms of finance, for the years 2022, 2023, and 2024, the company is expected to achieve operating income of approximately 279 million yuan, 325 million yuan, and 358 million yuan, respectively, and net profits of approximately 20.13 million yuan, 49.76 million yuan, and 58.81 million yuan, respectively.
Related Articles
ASCLETIS-B(01672): The weight loss effect of ASC47 combined with semaglutide in obese subjects is relatively increased by up to 56.2% compared to semaglutide monotherapy.

BEKE-W (02423) spent 4.4992 million US dollars on September 19 to repurchase 677,000 shares.

CENTURY EN INTL (08132) was accused of losing control of its mainland subsidiary. The Securities and Futures Commission applied to cancel the qualifications of four former directors.
ASCLETIS-B(01672): The weight loss effect of ASC47 combined with semaglutide in obese subjects is relatively increased by up to 56.2% compared to semaglutide monotherapy.
BEKE-W (02423) spent 4.4992 million US dollars on September 19 to repurchase 677,000 shares.

CENTURY EN INTL (08132) was accused of losing control of its mainland subsidiary. The Securities and Futures Commission applied to cancel the qualifications of four former directors.

RECOMMEND